Method for making hydrogen using a gold containing water-gas shift catalyst

Details for Australian Patent Application No. 2004255562 (hide)

Owner Chevron U.S.A., Inc.

Inventors Kuperman, Alexander; Moir, Michael E.

Agent Davies Collison Cave

Pub. Number AU-B-2004255562

PCT Pub. Number WO2005/005032

Priority 60/478,442 13.06.03 US

Filing date 10 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 19 November 2009

International Classifications

C01B 3/12 (2006.01) Hydrogen

B01J 21/06 (2006.01)

B01J 23/52 (2006.01) Catalysts comprising metals or metal oxides or hydroxides, not provided for in group

B01J 27/02 (2006.01) Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen - Sulfur, selenium or tellurium

B01J 27/055 (2006.01) Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen

B01J 31/00 (2006.01) Catalysts comprising hydrides, coordination complexes or organic compounds

B01J 35/00 (2006.01) Catalysts, in general, characterised by their form or physical properties

B01J 37/20 (2006.01) Processes, in general, for preparing catalysts

C01B 3/16 (2006.01) Hydrogen

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005032 Priority application(s): WO2005/005032

19 November 2009 Application Accepted

  Published as AU-B-2004255562

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255564-Methods for treating lentivirus infections

2004255557-Method of treating neurodegenerative disease